Presence of auto-antibody against two placental proteins, annexin A1 and vitamin D binding protein, in sera of women with pre-eclampsia

Journal of Reproductive Immunology

Volumn 99, Issue 1-2, 2013, Pages 10-16

  Behrouz, Gharesi Fard ^a,b   Farzaneh, Ghaderi shabankareh ^a   Leila, Jafarzadeh ^a   Jaleh, Zolghadri ^a,b   Eskandar, Kamali Sarvestani ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Annexin A1; Placenta; Pre eclampsia; Proteomics; Vitamin D binding protein

Indexed keywords

AUTOANTIBODY; LIPOCORTIN 1; MONOCLONAL ANTIBODY; POLYVINYLIDENE FLUORIDE; RNA; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANNEXIN A1; PLACENTA; PRE-ECLAMPSIA; PROTEOMICS; VITAMIN D BINDING PROTEIN;

ADULT; ANNEXIN A1; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; FEMALE; HUMANS; MASS SPECTROMETRY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PROTEOMICS; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

EID: 84883554168     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2013.04.007     Document Type: Article

References (37)

1. Allen J.Y., Tapia-Santiago C., Kutteh W.H. Antiphospholipid antibodies in patients with preeclampsia. Am. J. Reprod. Immunol. 1996, 36(2):81-85.
2. Biggioggero M., Meroni P.L. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun. Rev. 2010, 9(5):299-304.
3. Bodnar L.M., Catov J.M., Simhan H.N., Holick M.F., Powers R.W., Roberts J.M. Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 2007, 92(9):3517-3522.
4. Bushnell C., Chireau M. Preeclampsia and stroke: risks during and after pregnancy. Stroke Res. Treat. 2011, 2011:858134.
5. Chatterjee B.E., Yona S., Rosignoli G., Young R.E., Nourshargh S., Flower R.J., et al. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J. Leukoc. Biol. 2005, 78(3):639-646.
6. Evans K.N., Bulmer J.N., Kilby M.D., Hewison M. Vitamin D and placental-decidual function. J. Soc. Gynecol. Investig. 2004, 11(5):263-271.
7. Gerke V., Moss S.E. Annexins: from structure to function. Physiol. Rev. 2002, 82(2):331-371.
8. Gharesi-Fard B., Zolghadri J., Kamali-Sarvestani E. Proteome differences of placenta between pre-eclampsia and normal pregnancy. Placenta 2010, 31(2):121-125.
9. Goulding N.J., Podgorski M.R., Hall N.D., Flower R.J., Browning J.L., Pepinsky R.B., et al. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 1989, 48(10):843-850.
10. Gouni-Berthold I., Krone W., Berthold H.K. Vitamin D and cardiovascular disease. Curr. Vasc. Pharmacol. 2009, 7(3):414-422.
11. Grill S., Rusterholz C., Zanetti-Dallenbach R., Tercanli S., Holzgreve W., Hahn S., et al. Potential markers of preeclampsia-a review. Reprod. Biol. Endocrinol. 2009, 7:70.
12. Hewison M. Vitamin D and the immune system. Endocrinology 1992, 132:173-175.
13. Matsubayashi H., Arai T., Izumi S., Sugi T., McIntyre J.A., Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil. Steril. 2001, 76(4):694-699.
14. Moore K., Goulet F., Sartorelli A.C. Purification of annexin I and annexin II from human placental membranes by high-performance liquid chromatography. Protein. Expr. Purif. 1992, 3(1):1-7.
15. Myatt L. Role of placenta in preeclampsia. Endocrine 2002, 19(1):103-111.
16. Myatt L., Webster R.P. Vascular biology of preeclampsia. J. Thromb. Haemost. 2009, 7(3):375-384.
17. Namba F., Kitajima H., Tabata A., Nakayama M., Suehara N., Matsunami K., et al. Anti-annexin A2 IgM antibody in preterm infants: its association with chorioamnionitis. Pediatr. Res. 2006, 60(6):699-704.
18. Nestler J.E., McLeod J.F., Kowalski M.A., Strauss J.F., Haddad J.G. Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae. Endocrinology 1987, 120(5):1996-2002.
19. Neuhoff V., Arold N., Taube D., Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9(6):255-262.
20. Pandey M.K., Saxena V., Agrawal S. Characterization of mixed lymphocyte reaction blocking antibodies (MLR-Bf) in human pregnancy. BMC Preg. Childbirth 2003, 3(1):2.
21. Perretti M., Wheller S.K., Choudhury Q., Croxtall J.D., Flower R.J. Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus. Biochem. Pharmacol. 1995, 50(7):1037-1042.
22. Perretti M., Croxtall J.D., Wheller S.K., Goulding N.J., Hannon R., Flower R.J. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med. 1996, 2(11):1259-1262.
23. Podgorski M.R., Goulding N.J., Hall N.D., Flower R.J., Maddison P.J. Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis. J. Rheumatol. 1992, 19(11):1668-1671.
24. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010, 63(6):534-543.
25. Reslan O.M., Khalil R.A. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc. Hematol. Agents. Med. Chem. 2010, 8(4):204-226.
26. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357(9249):53-56.
27. Saito S., Shiozaki A., Nakashima A., Sakai M., Sasaki Y. The role of the immune system in preeclampsia. Mol. Aspects Med. 2007, 28(2):192-209.
28. Singh H.J. Pre-eclampsia: is it all in the placenta?. Malays. J. Med. Sci. 2009, 16(1):7-15.
29. Stevens T.R., Smith S.F., Rampton D.S. Antibodies to human recombinant lipocortin-I in inflammatory bowel disease. Clin. Sci. (Lond.) 1993, 84(4):381-386.
30. Sun M., Liu Y., Gibb W. Distribution of annexin I and II in term human fetal membranes, decidua and placenta. Placenta 1996, 17(2-3):181-184.
31. Valenzuela F.J., Pérez-Sepúlveda A., Torres M.J., Correa P., Repetto G.M., Illanes S.E. Pathogenesis of preeclampsia: the genetic component. J. Preg. 2012, 2012:632732.
32. Vanderlelie J., Gude N., Perkins A.V. Antioxidant gene expression in preeclamptic placentae: a preliminary investigation. Placenta 2008, 29(6):519-522.
33. VanWijk M.J., Kublickiene K., Boer K., VanBavel E. Vascular function in preeclampsia. Cardiovasc. Res. 2000, 47(1):38-48.
34. Wagner L.K. Diagnosis and management of preeclampsia. Am. Fam. Phys. 2004, 70(12):2317-2324.
35. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jüpner A., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 1999, 103(7):945-952.
36. Yamamoto T., Yoshimura S., Geshi Y., Sasamori Y., Mori H., Kobayashi T. Anti-ssDNA and dsDNA antibodies in preeclampsia. Asia-Oceania J. Obstet. Gynaecol. 1994, 20(1):93-99.
37. Yasuda M., Takakuwa K., Tokunaga A., Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet. Gynecol. 1995, 86(4 Pt 1):555-559.